Jaguar Health Reports Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer

July 23, 2024 8:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / July 23, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the results from its initial analysis of the pivotal Phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer patients with solid tumors receiving targeted therapy with or without standard chemotherapy. Crofelemer is an FDA-approved prescription drug for the symptomatic relief of diarrhea in adult HIV/AIDS...

Read more

Ankle & Foot Surgeons Keep Patients a Step Ahead with New Advanced Techniques

July 23, 2024 8:00 AM

The leader in podiatric care leverages industry-leading foot and ankle surgeon teams and state-of-the-art technology for patient outcomes that set new industry standards. PEACHTREE CITY, GA / ACCESSWIRE / July 23, 2024 / Renowned as a leader in podiatry for more than 40 years, Ankle & Foot Centers of America proudly announces new cutting-edge treatments for foot and ankle conditions, including bunions, plantar fasciitis, heel pain, and diabetic...

Read more

50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers

July 23, 2024 7:00 AM

Data points to a broader industry-wide imaging accuracy crisisCHICAGO, IL / ACCESSWIRE / July 23, 2024 / Yunu, a provider of medical research technology and services to life sciences companies and clinical research environments, hosted a recent panel at the Association for American Cancer Institutes' (AACI) Cancer Research Innovation (CRI) symposium that shed light on the alarming error and non-compliance rates for imaging assessments in...

Read more

David Rubenstein Joins Moderna's Board of Directors

July 23, 2024 7:00 AM

CAMBRIDGE, MA / ACCESSWIRE / July 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that David M. Rubenstein, Co-Founder and Co-Chairman of The Carlyle Group, will join Moderna's Board of Directors, effective August 5, 2024. Upon Mr. Rubenstein's appointment, directors Robert Langer and Stephen Berenson will also retire from the Board. Mr. Rubenstein will replace Mr. Berenson on the Audit Committee of the Board. Both Dr. Langer and Mr....

Read more

Relentless Health to Partner With Firefighters to Deliver PFAS Testing

July 22, 2024 2:45 PM

Relentless Health (formerly Diagnose Early) is partnering with the Professional Firefighters Association of South Carolina (PFFASC) to deliver at-home PFAS testingMENLO PARK, CA / ACCESSWIRE / July 22, 2024 / Today, Relentless Health (formerly Diagnose Early) provided details of our key partnership with the Professional Firefighters Association of South Carolina (PFFASC). Relentless Health has worked closely with the PFFASC as we develop our...

Read more

Global On-site Preventive Care Market to advance at a 5.2% CAGR from 2024 to 2034, accumulating USD 43.52 Billion | Future Market Insights, Inc.

July 22, 2024 11:00 AM

The global on-site preventive care market is estimated to be worth USD 26.21 billion in 2024 and is projected to be valued at USD 43.52 billion in 2034. From 2024 to 2034, the market is forecasted to rise at a 5.2% CAGR.With increasing emphasis on employee wellness, employers are increasingly investing in the health and well-being of their workforce, driving the growth of the on-site preventive care market during the forecast period.The on-site...

Read more

BMCS and Commodity Vault Enter Into The Real-World Assets Tokenization Ecosystem

July 22, 2024 10:00 AM

WOODLAND HILLS, CA / ACCESSWIRE / July 22, 2024 / BioTech Medics, Inc. (OTC PINK:BMCS) and its subsidiary Commodity Vault are pleased to announce that the firms have created the architecture for our RWA Tokenization Trading Platform that includes, tokens, various commodities, verified blockchains, white papers, apps, wallets, websites, stocks and strategic partnerships all of these components, and more encompass our ecosystem. This year...

Read more

Bristol Myers Squibb's Commitment to Environment, Social and Governance: Our Progress & Aspirational Goals

July 22, 2024 9:45 AM

NORTHAMPTON, MA / ACCESSWIRE / July 22, 2024 / Bristol Myers Squibb CompanyOur Approach to ESGAt BMS, we understand that the future of our company, employees, communities, and the planet are inextricably linked. Our passion for making an impact extends beyond the discovery, development and delivery of innovative medicines that help patients prevail over serious diseases. Through our ESG strategy, we seek to mobilize our capabilities and...

Read more

Lovemère Introduces the Smallest Ever Warming Lactation Massager to Enhance Breastfeeding and Pumping for Moms

July 22, 2024 9:06 AM

SINGAPORE, SINGAPORE / ACCESSWIRE / July 10, 2024 / Lovemère, a prominent innovator in maternity and nursing wear, proudly announces the launch of its latest product: the Lovemère Warming Lactation Massager. Designed to offer unmatched comfort and relief, this compact device aims to improve the breastfeeding and pumping experience for mothers.The Smallest Ever, Yet Most PowerfulThe Lovemère Warming Lactation Massager distinguishes itself as the...

Read more

A Place At Home Celebrates Strong First Half of 2024 With Eight New Units

July 22, 2024 9:00 AM

A Place At Home, a senior-focused home care provider franchise, is entering the second half of 2024 with momentum from a strong first half. The franchise successfully added eight new units, bringing the total to 59 across the nation."Our growth is a testament to the effectiveness of our proven business model and the demand for our services," said Jason Evanich, president and co-founder of A Place At Home. "Many of our franchisees are headed for...

Read more

Omni-Biotic AB 10 Wins Product of the Year at NutraIngredients USA Awards 2024

July 22, 2024 8:00 AM

NEW YORK, NY / ACCESSWIRE / July 22, 2024 / Omni-Biotic US is proud to announce that Omni-Biotic AB 10 has been awarded "Product of the Year" in the "Microbiome Modulation" category at this year's prestigious NutraIngredients USA Awards.Omni-Biotic AB 10 Omni-Biotic AB 10 Box and Sachet The judges highlighted Omni-Biotic AB 10's exceptional impact on gut health and its innovative approach to addressing gut dysbiosis, stating: "Supported by trial...

Read more

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance

July 22, 2024 8:00 AM

MIAMI, FL / ACCESSWIRE / July 22, 2024 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a leading pre-clinical-stage pharmaceutical company, today announced new preclinical study results for its novel oral ketamine analog, Ketamir-2.The additional data announced today continues a string of promising preclinical results announced by MIRA in recent months for Ketamir-2 as MIRA works towards its goal of submitting an...

Read more

Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024

July 22, 2024 7:00 AM

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one meetings at the BTIG Virtual Biotechnology Conference.BTIG Virtual Biotechnology Conference - August 5-6, 2024Format: Fireside ChatDay/Time: Tuesday, August 6 at 2:00-2:35 P.M. EDTIf you are interested in meeting with the Protagonist...

Read more

Biotricity Announces Continued Margin Improvement Driven by its Proprietary AI Cloud

July 22, 2024 7:00 AM

REDWOOD CITY, CA / ACCESSWIRE / July 22, 2024 / Biotricity Inc. (Nasdaq:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced ongoing improvements in operational efficiency, scalability and margin performance driven by the latest enhancements to the company's proprietary AI Cloud platform.The latest version of Biotricity's AI Cloud has improved the company's tech...

Read more

Tonix Pharmaceuticals Awarded Potential 34 million dollar Contract with U.S. Department of Defense

July 22, 2024 4:50 AM

Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to share exciting news about a significant achievement for the company. Tonix Pharmaceuticals has been awarded a potential contract worth up to $34 million over five years by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense. This contract aims to develop small molecule broad-spectrum antiviral agents for the prevention or...

Read more

Cantargia Reports Organisational Change

July 22, 2024 2:50 AM

LUND, SWEDEN / ACCESSWIRE / July 22, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today announced that its Chief Operating Officer (COO), Liselotte Larsson has resigned and will continue her career outside Cantargia. She will depart her role by mid-October, 2024."Liselotte joined Cantargia before our public listing and has played an important role to advance Cantargia's two projects into clinical stage, for which...

Read more

Biophytis Deploys its Partnership Strategy and Signs Two Contracts with Local Agents in Asia

July 22, 2024 2:30 AM

Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the development of treatments for age-related diseases, today announces the deployment of its partnership strategy in Asia.To expand its presence in this strategic region, Biophytis has today signed two contracts with local agents: one for Japan and South Korea, the other for China and Southeast Asia. These agents...

Read more

Lovemère Introduces the Smallest Ever Warming Lactation Massager to Enhance Breastfeeding and Pumping for Moms

July 20, 2024 11:25 AM

SINGAPORE, SINGAPORE / ACCESSWIRE / July 10, 2024 / Lovemère, a prominent innovator in maternity and nursing wear, proudly announces the launch of its latest product: the Lovemère Warming Lactation Massager. Designed to offer unmatched comfort and relief, this compact device aims to improve the breastfeeding and pumping experience for mothers.The Smallest Ever, Yet Most PowerfulThe Lovemère Warming Lactation Massager distinguishes itself as the...

Read more

Healthcare AI Acquisition Corp. Announces Receipt of Nasdaq Deficiency Letter

July 19, 2024 4:30 PM

Healthcare AI Acquisition Corp. (NASDAQ:HAIA) (the "Company"), a special purpose acquisition company, announced today that it received a notification letter from The Nasdaq Stock Market ("Nasdaq") that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2024 (the "Form 10-Q"). Under the Nasdaq Listing Rules, the Company now has 60 calendar...

Read more

Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule

July 19, 2024 11:40 AM

CHICAGO, IL / ACCESSWIRE / July 19, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has regained compliance with the minimum bid price requirement of...

Read more